Germano G , Kiat H , Kavanagh PB , Moriel M , Mazzanti M , Su HT.Automatic quantification of ejection fraction from gated myocardial perfusion SPECT . J Nucl Med1995; 36: 138-147 .
2.
Weiner HL , et al.Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of Northeast Cooperative Multiple Sclerosis Treatment Group . Neurology1993; 43: 910-918 .
3.
The Canadian Cooperative Multiple Sclerosis Study Group . The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis . Lancet1991; 23: 441-446 .
4.
Martin F , et al.Side-effects of intravenous cyclophosphamide pulse therapy . Lupus1997; 6: 254-257 .
5.
Brestescher C , et al.Chemotherapy and cardiotoxicity . Ann Cardiol Angeiol1995; 44: 443-447 .
6.
Pai VB , et al.Cardiotoxicity of chemotherapeutic agents: incidence, treatment and prevention . Drug Saf2000; 22: 263-302 .
7.
Basser RL , et al.Cardiac effects of high-dose epirubicin and cyclophosphamide in women with poor prognosis breast cancer . Ann Oncol1999; 10: 53-58 .
